NVNO:NASDAQenVVeno Medical Corporation analysis
Data as of Sep 18, 2026 - not real-time
- Latest price
- $8.98
- Risk: high
- 9/10High risk
Summary
The moving-average structure behind enVVeno Medical Corporation is bearish at $8.97, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 11.6%. With RSI at 34.7 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $7.01 and resistance around $11.95.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 234.3% above today's level.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 72.2%, a beta of 1.34 and a maximum drawdown of 74.6%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 1/10 long-term conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 234.3% above today's level.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 72.2%, a beta of 1.34 and a maximum drawdown of 74.6%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 1/10 long-term conviction.
Market outlook
Short term
< 1 yearCautious
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 10.93
- MACD momentum is negative
Medium term
1–3 yearsNeutral
Model confidence2/102 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 10.93
- Analyst targets imply +234.3% versus the current price
Long term
> 3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Analyst targets imply +234.3% versus the current price
- Negative return on equity of -58.5%
- Negative free cash flow
Key metrics
Financial health
P/E Ratio-1.4
ROE-58.53%
ROA-36.68%
Debt/Equity2.44
P/B Ratio0.3
Op. Cash Flow$-14622000
Free Cash Flow$-9590500
Industry P/E30.1
Technical analysis
TrendBearish
RSI34.7
Support$7.01
Resistance$11.95
MA 20$10.55
MA 50$10.64
MA 200$10.93
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98
Valuation
Target Price$30.00
Upside/Downside234.26%
GradeUndervalued
TypeBlend
Risk assessment
Beta1.34
Volatility72.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.